Diastolic Dysfunction and TAVR: Prognosis before and after Procedure

The PARTNER 2 SAPIEN 3 showed baseline diastolic dysfunction is a predictor of clinical events after 2 years of TAVR. As expected, improved diastolic function after procedure immediately changes prognosis. 

Función diastólica y TAVI

Though these outcomes did meet our expectations, very few studies have shown hard evidence linking diastolic dysfunction and aortic stenosis. 

All patients included in the PARTNER 2 SAPIEN 3 registry received an echocardiogram at baseline, at 30 days, one, and two years, to look into diastolic dysfunction, and were classified according to the American Society of Echocardiography diastolic dysfunction groups. 

Of 1750 patients in the registry, 682 (54.4%) showed diastolic dysfunction grade 1, 352 (28.1%) had grade 2 and 168 (13.4%) had grade 3. The rest of patients (4.1%) were undetermined.  

Diastolic dysfunction grade was associated to increased death and hospitalization at 1 and 2 years (p<0.002) and all cause death at 2 years (p=0.01).


Read also: Last Bastion of Bare Metal Stents Finally Falls.


70.8% of patients showed improved diastolic function after valve implantation. Those who showed at least one grade improvement in calcification after procedure showed reduced mortality and hospitalization rates at one year (p<0.001) and increased survival rate at 2 years (p=0.01).

A simple transthoracic echocardiogram 30 days after procedure can provide information on hard points at mid and long -term. 

Conclusion

The PARTNER 2 SAPIEN 3 has shown that baseline diastolic dysfunction, and its improvement after TAVR, can predict hard events at 2 years, including death. 

j-jacc-2020-10-032free

Original Title: Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement PARTNER 2 SAPIEN 3 Registry.

Reference: Geraldine Ong et al. J Am Coll Cardiol 2020;76:2940–51. https://doi.org/10.1016/j.jacc.2020.10.032


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...